Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Liabilities and Shareholders Equity (2016 - 2025)

Innospec's Liabilities and Shareholders Equity history spans 16 years, with the latest figure at $1.8 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 5.63% year-over-year to $1.8 billion; the TTM value through Dec 2025 reached $7.2 billion, up 3.55%, while the annual FY2025 figure was $1.8 billion, 5.63% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $1.8 billion at Innospec, up from $1.8 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $1.8 billion in Q4 2025 and bottomed at $1.4 billion in Q1 2021.
  • The 5-year median for Liabilities and Shareholders Equity is $1.7 billion (2022), against an average of $1.7 billion.
  • The largest annual shift saw Liabilities and Shareholders Equity grew 13.86% in 2022 before it dropped 3.03% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.6 billion in 2021, then increased by 2.09% to $1.6 billion in 2022, then rose by 6.47% to $1.7 billion in 2023, then grew by 1.6% to $1.7 billion in 2024, then grew by 5.63% to $1.8 billion in 2025.
  • Per Business Quant, the three most recent readings for IOSP's Liabilities and Shareholders Equity are $1.8 billion (Q4 2025), $1.8 billion (Q3 2025), and $1.8 billion (Q2 2025).